The flexibility and incompatibility of ICH Q12 guidelines with current EU legislations raise complications. As the world’s economy is increasingly threatened by new barriers to trade, the ...
The internationally harmonized guideline for a risk-based approach on assessing and controlling elemental impurities in drug products entered the final implementation phase. ICH Q3D(R1) Guideline for ...
The draft guidance ICH Q10 for pharmaceutical quality systems is part of the ongoing move to a science- and risk-based approach in manufacturing. The pharmaceutical industry's efforts to implement ...
13d
ICH GCP E6(R3): Navigating the New Era of Good Clinical Practice, Upcoming Webinar Hosted by Xtalks
The new ICH GCP E6(R3) guidance, effective July 2025, signals a significant shift towards more flexible, patient-centered and ...
DUBLIN--(BUSINESS WIRE)--The "The New ICH GCP E6 R2 Guideline" conference has been added to Research and Markets' offering With the new ICH GCP E6 Revision 2 changes now finalised and needing to be ...
The ICH M12 Guideline was finalized on May 21st, 2024, after extensive review of industry and other comments. The Guideline was the culmination of the extensive work by the Expert Working Group. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback